Brief: Y-mAbs Therapeutics Q3 Net Income USD -7 Million Vs. IBES Estimate USD -7.42 Million
08/11/2024 11:35
Nov 08 (Reuters) - Y-mAbs Therapeutics Q3 product revenue USD 18.5 million
Recent news on Y-mAbs Therapeutics
See all newsY-mAbs Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Y-mAbs Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Y-mAbs Therapeutics' Q2 revenue falls 14%
Brief: Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
Y-mAbs Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary